Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 13 | ||
Ligand | BDBM50473628 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_124318 (CHEMBL732626) | ||
IC50 | 62±n/a nM | ||
Citation | McKenna, JM; Halley, F; Souness, JE; McLay, IM; Pickett, SD; Collis, AJ; Page, K; Ahmed, I An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors. J Med Chem45:2173-84 (2002) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 13 | |||
Name: | Mitogen-activated protein kinase 13 | ||
Synonyms: | MAP kinase 13 | MAP kinase p38 delta | MAPK 13 | MK13_MOUSE | Mapk13 | Mitogen-activated protein kinase 13 | Mitogen-activated protein kinase p38 delta | Serk4 | Stress-activated protein kinase 4 | ||
Type: | PROTEIN | ||
Mol. Mass.: | 42081.17 | ||
Organism: | Mus musculus | ||
Description: | ChEMBL_105000 | ||
Residue: | 366 | ||
Sequence: |
| ||
BDBM50473628 | |||
n/a | |||
Name | BDBM50473628 | ||
Synonyms: | CHEMBL307604 | RPR-235315 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H29FN6O4 | ||
Mol. Mass. | 496.534 | ||
SMILES | COCCNC(=O)[C@]1(C)CO[C@@H](OC1)c1nc(c([nH]1)-c1ccnc(NCC=C)n1)-c1ccc(F)cc1 |wU:11.14,7.6,wD:7.7,(23.55,-.85,;22.21,-.1,;20.89,-.9,;19.34,-.91,;18.59,-2.25,;17.05,-2.27,;16.26,-.94,;16.29,-3.6,;17.05,-4.94,;15.51,-2.27,;13.99,-2.27,;13.23,-3.6,;13.99,-4.93,;15.51,-4.94,;11.68,-3.6,;10.77,-4.84,;9.3,-4.37,;9.3,-2.83,;10.77,-2.34,;7.97,-2.04,;7.97,-.5,;6.64,.27,;5.31,-.5,;5.31,-2.04,;3.97,-2.81,;2.64,-2.04,;1.29,-2.81,;-.04,-2.04,;6.64,-2.81,;8.06,-5.26,;8.21,-6.78,;6.97,-7.69,;5.56,-7.06,;4.21,-7.82,;5.4,-5.52,;6.66,-4.62,)| | ||
Structure |